Trials / Enrolling By Invitation
Enrolling By InvitationNCT04660526
RACE-CARS - RAndomized Cluster Evaluation of Cardiac ARrest Systems
RAndomized Cluster Evaluation of Cardiac ARrest Systems
- Status
- Enrolling By Invitation
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20,000 (estimated)
- Sponsor
- Duke University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RACE-CARS is a real-world cluster-randomized trial designed to evaluate a multifaceted community and health systems intervention aimed to improve outcomes of out-of-hospital cardiac arrest. RACE-CARS will enroll 50 counties in North Carolina that are estimated to have a total of approximately 20,000 patients with cardiac arrest over a 4-year intervention period. County "clusters" will be randomized in a 1:1 ratio to intervention versus usual care. The trial duration is 7 years, which includes a 6-month start-up (including recruitment and randomization) period, a 12-month intervention training phase, a 4-year intervention period, a 12-month follow-up for to assess quality of life in survivors of OHCA, and a 6-month close-out and data analysis period.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Rapid cardiac arrest recognition that triggers immediate priority EMS/first responder dispatch by 911 operators | EMS first responders will recognize cardiac arrest and respond immediately, increasing time to dispatch |
| OTHER | Systematic bystander resuscitation instruction by 911 operators | 911 operators will be able to describe how to administer CPR over the phone. |
| OTHER | Comprehensive community training of lay people in CPR and AED use. | Training of lay people regarding CPR and AED use. |
| OTHER | Optimized first responder performance including earlier use of AEDs. | First responders will recognize where AEDs are located and use them appropriately |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2027-06-30
- Completion
- 2027-06-30
- First posted
- 2020-12-09
- Last updated
- 2025-04-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04660526. Inclusion in this directory is not an endorsement.